Inspire Veterinary Partners, Inc. (IVP)
NASDAQ: IVP · Real-Time Price · USD
0.188
+0.001 (0.27%)
At close: Dec 20, 2024, 4:00 PM
0.190
+0.003 (1.44%)
After-hours: Dec 20, 2024, 7:55 PM EST

Company Description

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States.

The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds, including equine care.

Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services.

It also offers surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services.

The company was incorporated in 2020 and is based in Virginia Beach, Virginia.

Inspire Veterinary Partners, Inc.
Inspire Veterinary Partners logo
Country United States
Founded 2020
IPO Date Aug 30, 2023
Industry Personal Services
Sector Consumer Discretionary
Employees 156
CEO Kimball Carr

Contact Details

Address:
780 Lynnhaven Parkway, Suite 400
Virginia Beach, Virginia 23452
United States
Phone 757 734 5464
Website inspirevet.com

Stock Details

Ticker Symbol IVP
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.00
CIK Code 0001939365
CUSIP Number 45784E106
ISIN Number US45784E1064
Employer ID 85-4359258
SIC Code 0700

Key Executives

Name Position
Kimball Carr Chairman, Chief Executive Officer and President
Richard Paul Frank Chief Financial Officer
Dr. Alexandra Quatri Vice President of Medical Operations
Lynley Kees Vice President of Human Resources
Zander Carraway Director of Acquisitions
Debbe Bastian Finance Controller

Latest SEC Filings

Date Type Title
Dec 18, 2024 8-K Current Report
Dec 10, 2024 DEF 14C Filing
Nov 18, 2024 PRE 14C Filing
Nov 13, 2024 10-Q Quarterly Report
Oct 23, 2024 8-K Current Report
Oct 22, 2024 424B5 Filing
Oct 15, 2024 8-K Current Report
Oct 11, 2024 EFFECT Notice of Effectiveness
Oct 11, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 8, 2024 S-3/A [Amend] Registration statement under Securities Act of 1933